Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.4B; returns 1 day +2.2%, 1 week +2.2%, 1 year +412.2%.

Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics for high-prevalence retinal diseases, which are leading causes of blindness globally. The company currently has no approved products and, therefore, generates no revenue.

Groups KOD belongs to

• Biotechnology
• Ophthalmology
• Clinical Stage
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Clinical Stage Biopharma
• Antibody-Drug Conjugates
• Antibody Therapeutics
• Life Sciences

KOD financial model: income statement, cash flow and balance sheet